We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$32.7B
AUM Growth
+$3.09B
Cap. Flow
-$420M
Cap. Flow %
-1.28%
Top 10 Hldgs %
43.68%
Holding
304
New
20
Increased
64
Reduced
125
Closed
15

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$101M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$90.4M
3
CME icon
CME Group
CME
+$76.1M
4
HD icon
Home Depot
HD
+$58M
5
NVDA icon
NVIDIA
NVDA
+$55.9M

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$323M
2
KO icon
Coca-Cola
KO
+$130M
3
JPM icon
JPMorgan Chase
JPM
+$125M
4
APD icon
Air Products & Chemicals
APD
+$102M
5
PM icon
Philip Morris
PM
+$73.3M

Sector Composition

Rank Sector Weight
1 Technology 25.51%
2 Financials 17.3%
3 Healthcare 13.2%
4 Consumer Staples 12.87%
5 Energy 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBA
126
DELISTED
Walgreens Boots Alliance
WBA
$3.06M 0.01%
137,678
-29,789
-18% -$666K
STZ icon
127
Constellation Brands
STZ
$21.3B
$3.04M 0.01%
12,520
+100
+0.8% +$23.8K
DE icon
128
Deere & Co
DE
$184B
$3.01M 0.01%
7,891
-753
-9% -$284K
EMR icon
129
Emerson Electric
EMR
$82.7B
$2.99M 0.01%
28,975
+156
+0.5% +$14.3K
SYY icon
130
Sysco
SYY
$40B
$2.9M 0.01%
36,454
-1,571
-4% -$108K
SPY icon
131
State Street SPDR S&P 500 ETF Trust
SPY
$803B
$2.72M 0.01%
5,422
-4,658
-46% -$2.07M
REGN icon
132
Regeneron Pharmaceuticals
REGN
$81.7B
$2.62M 0.01%
2,749
+74
+3% +$60.9K
CNP icon
133
CenterPoint Energy
CNP
$25.5B
$2.55M 0.01%
92,751
-15,225
-14% -$423K
MDT icon
134
Medtronic
MDT
$120B
$2.5M 0.01%
29,362
-19,800
-40% -$1.51M
SLB icon
135
SLB Ltd
SLB
$79.1B
$2.39M 0.01%
56,011
-5,717
-9% -$311K
TMO icon
136
Thermo Fisher Scientific
TMO
$227B
$2.11M 0.01%
3,826
+184
+5% +$89.1K
PAYX icon
137
Paychex
PAYX
$42.2B
$2.07M 0.01%
16,836
-676
-4% -$80.1K
FISV
138
Fiserv Inc
FISV
$27.1B
$2.02M 0.01%
14,024
+580
+4% +$71.2K
QQQ icon
139
Invesco QQQ Trust
QQQ
$477B
$1.99M 0.01%
4,559
+325
+8% +$123K
DHR icon
140
Danaher
DHR
$143B
$1.97M 0.01%
8,095
-965
-11% -$205K
GD icon
141
General Dynamics
GD
$96.5B
$1.91M 0.01%
7,088
+97
+1% +$23.7K
CSCO icon
142
Cisco
CSCO
$434B
$1.85M 0.01%
36,809
-1,010
-3% -$51.6K
ETN icon
143
Eaton
ETN
$153B
$1.7M 0.01%
6,100
-171
-3% -$37.7K
MAS icon
144
Masco
MAS
$13.7B
$1.65M 0.01%
22,675
-3,845
-14% -$223K
LOW icon
145
Lowe's Companies
LOW
$111B
$1.63M 0.01%
7,348
-422
-5% -$85.5K
TSLA icon
146
Tesla
TSLA
$1.42T
$1.52M ﹤0.01%
7,873
+511
+7% +$121K
NSC icon
147
Norfolk Southern
NSC
$71.9B
$1.48M ﹤0.01%
5,819
WM icon
148
Waste Management
WM
$87.2B
$1.44M ﹤0.01%
7,637
-2
-0% -$335
VLO icon
149
Valero Energy
VLO
$110B
$1.38M ﹤0.01%
9,654
-584
-6% -$74.3K
CMI icon
150
Cummins
CMI
$74.5B
$1.34M ﹤0.01%
5,330
-1,645
-24% -$374K

Similar funds

Fayez Sarofim & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Fayez Sarofim & Co held 304 positions worth $32.7B, up 10% from $29.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fayez Sarofim & Co's Q4 2023 filing shows 20 new, 64 increased, 125 reduced and 15 closed positions. Its largest new stake was ServiceNow: 438,825 shares worth $71.3M. The largest sale was ASML, an estimated $323M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Fayez Sarofim & Co's largest Q4 2023 buy was ServiceNow: 438,825 shares worth $71.3M.
  • Fayez Sarofim & Co added most to Intuit in Q4 2023, an estimated $101M increase.
  • Fayez Sarofim & Co's biggest Q4 2023 reduction was Coca-Cola, cutting an estimated $130M.
  • Fayez Sarofim & Co fully exited ASML in Q4 2023, selling an estimated $323M.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $32.7B portfolio in Q4 2023.
  • Fayez Sarofim & Co opened 20 new positions and closed 15 in Q4 2023.
  • Fayez Sarofim & Co's portfolio value rose 10% quarter-over-quarter to $32.7B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2023, filed 15 Feb 2024.